The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

The MITRA-HR study: design and rationale of a randomised study of MITRACLIP® transcatheter mitral valve repair in patients with severe primary mitral regurgitation eligible for high-risk surgery

EuroIntervention 2019; just accepted article published in April 2019. DOI: 10.4244/EIJ-D-18-01086

1. Institut du Thorax, Center Hospitalier Universitarie de Nantes, Nantes, France, FRANCE; 2. Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France; 3. Centre Hospitalier Universitaire de Rennes, Service de Cardiologie, Rennes, France; 4. Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France; 5. Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France; 6. Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France; 7. Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France; 8. Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France; 9. Centre Hospitalier Universitaire de Nantes; 10. Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, DHU Fire, Université Paris Diderot, Paris, France; 11. Service de Chirurgie Cardiothoracique et Transplantation, Hôpital Cardiothoracique Louis Pradel, Lyon-Bron, France; 12. Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, DHU Fire, Université Paris Diderot, Paris, France; 13. Institut du Thorax, Centre Hospitalier Universitaire de Nantes, Nantes, France
Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.

Aims: Percutaneous mitral valve repair has become an alternative to conventional surgery in patients suffering primary mitral regurgitation (MR) with a contraindication to surgery and could benefit patients at high surgical risk. The aim of the MITRA-HR study is to raise the level of evidence supporting the use of the MitraClip® device in primary MR patients with a pre-defined high risk for surgery.

Methods and results: MITRA-HR is a prospective, multicentre, randomised study designed to compare mitral valve repair using MitraClip® with conventional surgery in patients with severe primary mitral regurgitation at high risk for surgery. The surgical risk is defined by age, Society of Thoracic Surgeons (STS) risk estimate score, frailty, major organ system dysfunction, and procedure-specific impediments. The study will enrol 330 patients randomised between conventional surgery and MitraClip® with a 1:1 ratio. The composite primary endpoint includes all-cause mortality, unplanned rehospitalisation for cardiovascular reasons, and mitral valve reintervention at 12 months. The main secondary safety endpoint is a major adverse event composite assessment evaluated 30 days after the procedure.

Conclusions: The randomised MITRA-HR study is designed to provide additional supportive evidence of non-inferiority in efficacy and superiority in safety for percutaneous mitral valve repair using MitraClip® compared to conventional surgery in high surgical risk patients.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Feasibility of Robotic Telestenting Over Long Geographic Distances A Pre-clinical Ex Vivo and In Vivo Study